Clinical Trial Update: A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biologic Effect of VG2062 in Patients With Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial to evaluate VG2062 in patients with solid tumors is currently recruiting, assessing safety, tolerability, pharmacokinetics, and biologi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• VG2062

Snippet

Sponsor: Shanghai Virogin Biotech Co., Ltd. | Conditions: Advanced Malignant Solid Tumor | Phase 1 | Status: RECRUITING